Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.75 USD | +0.52% | -6.68% | -6.45% |
May. 09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
May. 08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.45% | 326M | |
+7.87% | 33.82B | |
+19.82% | 7.85B | |
+31.37% | 4.28B | |
-29.16% | 2.64B | |
-28.03% | 1.3B | |
-30.53% | 1.14B | |
+11.73% | 987M | |
-35.42% | 901M | |
-20.93% | 696M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- HC Wainwright Adjusts LifeMD Price Target to $12 From $10, Maintains Buy Rating